Patent intelligence · US
US 12419938
Proenzyme composition
Proenzyme composition
Patent details — US 12419938
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 23, 2025
- Expiration
- Sep 18, 2045
- Applicant
- Propanc Pty Ltd
- Claims
- 4
- CPC classes
- A61K, A61K38/4826, A61K9/0019, A61P
Quick answer
US 12419938 (Proenzyme composition) is held by Propanc Pty Ltd. Status: granted. Granted Sep 23, 2025. Expires Sep 18, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Propanc Pty Ltd
- Grant date
- Expiration
- Claims
- 4
- CPC classes
- A61K, A61K38/4826, A61K9/0019, A61P, A61P35/00
More from Propanc Pty Ltd
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 12419938?
US 12419938 (Proenzyme composition) is held by Propanc Pty Ltd. Status: granted. Granted Sep 23, 2025. Expires Sep 18, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12419938?
Propanc Pty Ltd is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does US 12419938 expire?
Our index shows an expiration date of Sep 18, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.